172 related articles for article (PubMed ID: 23146657)
1. Comparison of mastoscopic and conventional axillary lymph node dissection in breast cancer: long-term results from a randomized, multicenter trial.
Luo C; Guo W; Yang J; Sun Q; Wei W; Wu S; Fang S; Zeng Q; Zhao Z; Meng F; Huang X; Zhang X; Li R; Ma X; Luo C; Yang Y
Mayo Clin Proc; 2012 Dec; 87(12):1153-61. PubMed ID: 23146657
[TBL] [Abstract][Full Text] [Related]
2. 17-Year Follow-up of Comparing Mastoscopic and Conventional Axillary Dissection in Breast Cancer: A Multicenter, Randomized Controlled Trial.
Luo C; Wei C; Guo W; Yang J; Sun Q; Wei W; Wu S; Fang S; Zeng Q; Zhao Z; Meng F; Huang X; Zhang X; Li R; Ma X; Luo C; Yang Y
Adv Ther; 2022 Jun; 39(6):2961-2970. PubMed ID: 35486221
[TBL] [Abstract][Full Text] [Related]
3. Contrast of Mastoscopic and Conventional Axillary Lymph Node Dissection of Patients With Breast Cancer: Meta-Analysis.
Xiong H; Chen Z; Xu L; Chen C; Fu Q; Teng R; Chen J; Xie S; Wang L; Yu XF; Zhou J
Cancer Control; 2020; 27(2):1073274820932987. PubMed ID: 32602366
[TBL] [Abstract][Full Text] [Related]
4. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
5. Disease recurrence in sentinel node-positive breast cancer patients forgoing axillary lymph node dissection.
Cyr A; Gao F; Gillanders WE; Aft RL; Eberlein TJ; Margenthaler JA
Ann Surg Oncol; 2012 Oct; 19(10):3185-91. PubMed ID: 22890591
[TBL] [Abstract][Full Text] [Related]
6. Feasibility analysis of treating breast cancer patients with breast-conserving surgery via a periareolar incision combined with non-lipolytic suspension-type mastoscopy.
Liu J; He G; Zhang Y; Wong MP; Chu J; Kong L; Yahya MM
Sci Rep; 2023 Jul; 13(1):12129. PubMed ID: 37495629
[TBL] [Abstract][Full Text] [Related]
7. Experience of a large series of mastoscopic axillary lymph node dissection.
Chengyu L; Jian Z; Xiaoxin J; Hua L; Qi Y; Chen G
J Surg Oncol; 2008 Aug; 98(2):89-93. PubMed ID: 18484080
[TBL] [Abstract][Full Text] [Related]
8. The changing landscape of axillary surgery: which breast cancer patients may still benefit from complete axillary lymph node dissection?
McGhan LJ; Dueck AC; Gray RJ; Wasif N; McCullough AE; Pockaj BA
J Surg Oncol; 2012 Sep; 106(3):254-9. PubMed ID: 22034211
[TBL] [Abstract][Full Text] [Related]
9. Sentinel node positive breast cancer patients who do not undergo axillary dissection: are they different?
Zakaria S; Pantvaidya G; Reynolds CA; Grant CS; Sterioff S; Donohue JH; Farley DR; Hoskin TL; Degnim AC
Surgery; 2008 May; 143(5):641-7. PubMed ID: 18436012
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
11. A standardized surgical technique for mastoscopic axillary lymph node dissection.
Chengyu L; Yongqiao Z; Hua L; Xiaoxin J; Chen G; Jing L; Jian Z
Surg Laparosc Endosc Percutan Tech; 2005 Jun; 15(3):153-9. PubMed ID: 15956900
[TBL] [Abstract][Full Text] [Related]
12. Factors that determine whether a patient receives completion axillary lymph node dissection after a positive sentinel lymph node biopsy for breast cancer in British Columbia.
Aslani N; Swanson T; Kennecke H; Woods R; Davis N
Can J Surg; 2011 Aug; 54(4):237-42. PubMed ID: 21651836
[TBL] [Abstract][Full Text] [Related]
13. Sentinel lymph node biopsy in multicentric breast cancer: five-year results in a large series from a single institution.
Gentilini O; Veronesi P; Botteri E; Soggiu F; Trifirò G; Lissidini G; Galimberti V; Musmeci S; Raviele PR; Toesca A; Ratini S; Del Castillo A; Colleoni M; Talakhadze N; Rotmensz N; Viale G; Veronesi U; Luini A
Ann Surg Oncol; 2011 Oct; 18(10):2879-84. PubMed ID: 21479691
[TBL] [Abstract][Full Text] [Related]
14. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
15. [Standardized skill of mastoscopic axillary lymph node dissection].
Luo CY; Ji XX; Zhang J; Lin H; Yang Q; Guan C
Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(1):21-4. PubMed ID: 15774168
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.
Milgrom S; Cody H; Tan L; Morrow M; Pesce C; Setton J; Rogers K; Arnold B; Eaton A; Catalano J; McCormick B; Powell S; Ho A
Ann Surg Oncol; 2012 Nov; 19(12):3762-70. PubMed ID: 22576064
[TBL] [Abstract][Full Text] [Related]
17. Overview of the pathological results and treatment characteristics in the first 1000 patients randomized in the SERC trial: axillary dissection versus no axillary dissection in patients with involved sentinel node.
Houvenaeghel G; Cohen M; Raro P; De Troyer J; de Lara CT; Gimbergues P; Gauthier T; Faure-Virelizier C; Vaini-Cowen V; Lantheaume S; Regis C; Darai E; Ceccato V; D'Halluin G; Del Piano F; Villet R; Jouve E; Beedassy B; Theret P; Gabelle P; Zinzindohoue C; Opinel P; Marsollier-Ferrer C; Dhainaut-Speyer C; Colombo PE; Lambaudie E; Tallet A; Boher JM;
BMC Cancer; 2018 Nov; 18(1):1153. PubMed ID: 30463611
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of clinically node-negative breast cancer without axillary dissection: can preserved axilla be safely treated with radiation after a positive sentinel node biopsy?
Sanuki N; Takeda A; Amemiya A; Ofuchi T; Ono M; Ogata H; Yamagami R; Hatayama J; Eriguchi T; Kunieda E
Clin Breast Cancer; 2013 Feb; 13(1):69-76. PubMed ID: 23062706
[TBL] [Abstract][Full Text] [Related]
19. Survival analysis of early-stage breast cancer patients undergoing axillary lymph node dissection and sentinel lymph node dissection.
Nayyar A; Strassle PD; Shen MR; Black JA; Gallagher KK; McGuire KP
Am J Surg; 2018 Oct; 216(4):706-712. PubMed ID: 30060915
[TBL] [Abstract][Full Text] [Related]
20. [Mastoscopic axillary lymph node dissection for the patients with breast cancer].
Luo CY; Zhang J; Lin H; Yang Q; Huang X; Xue L; Zhang YZ; Li GH
Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(22):1946-8. PubMed ID: 14703427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
